Ultimately, CM-DOP inhibited the migration of gastric cancer cells by reversing the effects of N-cadherin and vimentin, as well as increasing the E-cadherin expression; meanwhile, CM-DOP upregulated Caspase-3 and increased the ratio of Bax/Bcl-2, thereby inducing apoptosis. The gene discussed is VIM; the disease is gastric cancer.